These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34324916)

  • 1. The role of sleep disorders in cardiovascular diseases: Culprit or accomplice?
    Wang Q; Wang X; Yang C; Wang L
    Life Sci; 2021 Oct; 283():119851. PubMed ID: 34324916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interplay between sleep and gut microbiota.
    Han M; Yuan S; Zhang J
    Brain Res Bull; 2022 Mar; 180():131-146. PubMed ID: 35032622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbid Sleep Disturbances in Neurologic Disorders.
    Ju YS; Videnovic A; Vaughn BV
    Continuum (Minneap Minn); 2017 Aug; 23(4, Sleep Neurology):1117-1131. PubMed ID: 28777179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders.
    Tsuneki H; Wada T; Sasaoka T
    Pharmacol Ther; 2018 Jun; 186():25-44. PubMed ID: 29289556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered extracellular vesicles and their mimics in cardiovascular diseases.
    Lai J; Huang C; Guo Y; Rao L
    J Control Release; 2022 Jul; 347():27-43. PubMed ID: 35508222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexin: a Missing Link Between Sleep Disorders and Heart Failure?
    Pan S; Cabral CS; Ashley EA; Perez MV
    Curr Heart Fail Rep; 2017 Apr; 14(2):100-105. PubMed ID: 28215031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbes in cardiovascular diseases and their potential therapeutic applications.
    Jin L; Shi X; Yang J; Zhao Y; Xue L; Xu L; Cai J
    Protein Cell; 2021 May; 12(5):346-359. PubMed ID: 32989686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep and Stroke.
    Mims KN; Kirsch D
    Sleep Med Clin; 2016 Mar; 11(1):39-51. PubMed ID: 26972032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review).
    Zhu Y; Shui X; Liang Z; Huang Z; Qi Y; He Y; Chen C; Luo H; Lei W
    Int J Mol Med; 2020 Sep; 46(3):936-948. PubMed ID: 32705240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles in Cardiovascular Theranostics.
    Bei Y; Das S; Rodosthenous RS; Holvoet P; Vanhaverbeke M; Monteiro MC; Monteiro VVS; Radosinska J; Bartekova M; Jansen F; Li Q; Rajasingh J; Xiao J
    Theranostics; 2017; 7(17):4168-4182. PubMed ID: 29158817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends in orexin research--2010 to 2015.
    Boss C; Roch C
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2875-87. PubMed ID: 26045032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease pathogenesis: The role of disturbed sleep in attenuated brain plasticity and neurodegenerative processes.
    Havekes R; Heckman PRA; Wams EJ; Stasiukonyte N; Meerlo P; Eisel ULM
    Cell Signal; 2019 Dec; 64():109420. PubMed ID: 31536750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Gut Microbiota-Derived Toxins Are Closely Associated with Cardiovascular Diseases: A Review.
    Yamashita T; Yoshida N; Emoto T; Saito Y; Hirata KI
    Toxins (Basel); 2021 Apr; 13(5):. PubMed ID: 33921975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular autonomic dysfunctions and sleep disorders.
    Calandra-Buonaura G; Provini F; Guaraldi P; Plazzi G; Cortelli P
    Sleep Med Rev; 2016 Apr; 26():43-56. PubMed ID: 26146026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep: important considerations for the prevention of cardiovascular disease.
    Grandner MA; Alfonso-Miller P; Fernandez-Mendoza J; Shetty S; Shenoy S; Combs D
    Curr Opin Cardiol; 2016 Sep; 31(5):551-65. PubMed ID: 27467177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular consequences of sleep-disordered breathing.
    Dopp JM; Morgan BJ
    J Cardiopulm Rehabil; 2006; 26(3):123-30. PubMed ID: 16738447
    [No Abstract]   [Full Text] [Related]  

  • 17. Sleep in Schizophrenia: Pathology and Treatment.
    Benson KL
    Sleep Med Clin; 2015 Mar; 10(1):49-55. PubMed ID: 26055673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic orexin and mechanistic target of rapamycin activation mediate sleep dysfunction in a mouse model of tuberous sclerosis complex.
    Zhang B; Guo D; Han L; Rensing N; Satoh A; Wong M
    Neurobiol Dis; 2020 Feb; 134():104615. PubMed ID: 31605778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review.
    Shariq AS; Rosenblat JD; Alageel A; Mansur RB; Rong C; Ho RC; Ragguett RM; Pan Z; Brietzke E; McIntyre RS
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():1-7. PubMed ID: 30576764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid β and tau are involved in sleep disorder in Alzheimer's disease by orexin A and adenosine A(1) receptor.
    Liu Z; Wang F; Tang M; Zhao Y; Wang X
    Int J Mol Med; 2019 Jan; 43(1):435-442. PubMed ID: 30365112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.